Click Here! Click Here!
 
Click Here!
 
 
 

 

 

Breast cancer
Impact of internal mammary node irradiation in high-risk patients

Caroline Chung, MD, MSc, CIP, FRCPC, Assistant Professor, Department of Radiation Oncology, University of Toronto; Radiation Oncologist and Clinician Investigator, Princess Margaret Hospital, Toronto.

To view the complete article click here (pdf format)

 

TRIAL SUMMARY: No benefit with internal mammary node inclusion in locoregional radiotherapy

 

To view the complete article click here (pdf format)

 
Back to Top of Page 

 

 
 

Canadian Association Of Radiation Oncology (CARO)
September 7-11, 2011, Winnipeg, Manitoba.

In Brief

Already known

  • Adjuvant locoregional radiotherapy to the breast/chest wall and locoregional lymph nodes, including the internal mammary nodes, results in better outcomes in women with node-positive or high-risk node-negative breast cancer.

What this study showed

  • With a relatively short median followup of 6.2 years, inclusion of the internal mammary chain did not demonstrate added benefit to irradiation of the breast/chest wall and axillary regional lymph nodes.

Next steps

  • Advances in radiation delivery techniques may minimize normal tissue dose when treating the regional lymph nodes and breast/chest wall.
  • Prospective studies randomizing patients to locoregional radiotherapy with or without IMN irradiation are needed.
  • Advanced staging investigations will improve selection of patients for IMN irradiation.
Click Here! Click Here!
© Parkhurst Publishing Privacy Statement
Legal Terms of Use